ReviewEuropean radiology2006
Smoking-related interstitial lung diseases: radiologic-pathologic correlation.
Review in European radiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.
- An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.American journal of respiratory and critical care medicine · 2013Guideline
- A CT-based score for predicting histopathological usual interstitial pneumonia features and predicting disease progression in smokers with fibrotic idiopathic interstitial pneumonia.European radiology · 2026Article
- Non-metastatic causes of multiple pulmonary nodules.Insights into imaging · 2024Article
- [Smoking-related interstitial lung disease : Radiological findings, histopathological correlations, and clinical observations].Radiologie (Heidelberg, Germany) · 2024Article
- Noninfectious Granulomatous Lung Disease: Radiological Findings and Differential Diagnosis.Journal of personalized medicine · 2024Review
- Langerhans Cell Histiocytosis Appearing as Wandering Pulmonary Nodules.Internal medicine (Tokyo, Japan) · 2022Article
- [Smoking-related interstitial lung diseases].Radiologie (Heidelberg, Germany) · 2022Review
- Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19.Japanese journal of radiology · 2021Review
- Pulmonary Langerhans Cell Histiocytosis in a young Non-Smoking Female --Too many Rituals spoil the Lung.Acta bio-medica : Atenei Parmensis · 2021Article
- Desquamative interstitial pneumonia: still orphan and not always benign.European respiratory review : an official journal of the European Respiratory Society · 2020Article
- Article
- Systemic Complications and Radiographic Findings of Opioid Use and Misuse: An Overview for Orthopedic Surgeons.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2019Review
- Desquamative interstitial pneumonia: Risk factors, laboratory and bronchoalveolar lavage findings, radiological and histopathological examination, clinical features, treatment and prognosis.Experimental and therapeutic medicine · 2019Review
- Diagnosis of Idiopathic Pulmonary Fibrosis: Differential Diagnosis.Medical sciences (Basel, Switzerland) · 2018Review
- Differential Diagnosis of Cavitary Lung Lesions.Journal of the Belgian Society of Radiology · 2016Article
- Smoking-related interstitial fibrosis combined with pulmonary emphysema: computed tomography-pathologic correlative study using lobectomy specimens.International journal of chronic obstructive pulmonary disease · 2016Article
- [Current classification of interstitial pulmonary diseases].Der Radiologe · 2014Article
- Pulmonary Langerhans cell histiocytosis: the many faces of presentation at initial CT scan.Insights into imaging · 2014Article
- Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology.European respiratory review : an official journal of the European Respiratory Society · 2013Review
- Mimics in chest disease: interstitial opacities.Insights into imaging · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Smoking-related interstitial lung diseases (SRILD) are a heterogeneous group of entities of unknown cause. These diseases include desquamative interstitial pneumonia (DIP), respiratory-bronchiolitis-related interstitial lung disease (RB-ILD), pulmonary Langerhans' cell histiocytosis (LCH) and idiopathic pulmonary fibrosis (IPF). High-resolution CT is highly sensitive in the detection of abnormalities in the lung parenchyma and airways. Ground-glass attenuation can occur in DIP and RB-ILD. Whereas DIP is histologically characterized by intra-alveolar pigmented macrophages, RB-ILD shows alveolar macrophages in a patchy peribronchiolar distribution. LCH shows nodular infiltrates on histopathological examination containing varying amounts of characteristic Langerhans' histiocytes. The HRCT findings are characteristically bilateral, symmetrical and diffuse, involving the upper lobe zones with sparing of the costophrenic angles. The most prominent CT features are nodules (sometimes cavitary) measuring 1 to 10 mm in diameter, cysts and areas of ground-glass attenuation. Pathologically, IPF is characterized by its heterogeneity with areas of normal lung, alveolitis and end-stage fibrosis shown in the same biopsy specimen. High-resolution CT findings consist of honeycombing, traction bronchiectasis and intralobular interstitial thickening with subpleural and lower lung predominance. Since coexisting lesions in the same cases have been observed, a better understanding of the different smoking-related interstitial lung diseases (SRILD) allows a more confident and specific diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.